Psychiatric considerations in the patient receiving organ transplantation: A clinical case conference

General Hospital Psychiatry

Volumn 25, Issue 6, 2003, Pages 484-491

  Huffman, Jeff C ^a,b,c   Popkin, Michael K ^d,e   Stern, Theodore A ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXIS; CASE REPORT; CONSULTATION; DRUG OVERDOSE; FEMALE; FOLLOW UP; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL ASSESSMENT; MEDICAL INFORMATION; ORGAN TRANSPLANTATION; PEROPERATIVE CARE; SOCIAL SUPPORT; SURGICAL TECHNIQUE;

EID: 0346963284     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(03)00090-2     Document Type: Article

References (17)

1. House R.M. Transplantation surgery. Stoudemire A., Fogel B.S. Psychiatric care of the medical patient. 1993;803-816 American Psychiatric Press, Washington, DC.
2. Chacko R.C., Harper R.G., Gotto J., et al. Psychiatric interview and psychometric predictors of cardiac transplant survival. Am J Psychiatry. 153:1996;1607-1612.
3. Shapiro P.A., Williams D.L., Foray A.T., et al. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 60:1995;1462-1466.
4. Yates W.R., LaBrecque D.R., Pfab D. Personality disorder as a contraindication for liver transplantation in alcoholic cirrhosis. Psychosomatics. 39:1998;501-511.
5. Rocca P., Marchiaro L., Cocuzza E., et al. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry. 63:2002;241-244.
6. Adityanjee A., Schulz S.C. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry. 63:(Suppl 13):2002;32-38.
7. Zanarini M.C., Frankenburg F.R. Olanzapine treatment of female borderline personality disorder patients a double-blind, placebo-controlled pilot study . J Clin Psychiatry. 62:2001;849-854.
8. Trzepacz P.T., Brenner R., Coffman G., et al. Delirium in liver transplantation candidates discriminant analysis of multiple test variables . Biol Psychiatry. 24:1988;3-14.
9. House R.M., Dubovsky S.L., Penn I. Psychiatric aspects of hepatic transplantation. Transplantation. 36:1983;146-150.
10. Fukunishi I., Sugawara Y., Takayama T., et al. Psychiatric disorders before and after living related transplantation. Psychosomatics. 42:2001;337-343.
11. Wagner W., Vause E.W. Fluvoxamine. A review of global drug-drug interaction data. Clin Pharmacokinet. 29:(Suppl 1):1995;26-31.
12. Vella J.P., Sayegh M.H. Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis. 31:1998;320-323.
13. Wright D.H., Lake K.D., Bruhn P.S., et al. Nefazodone and cyclosporine drug-drug interaction. J Heart Lung Transplant. 18:1999;913-915.
14. Breitbart W., Tremblay A., Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics. 43:2002;175-182.
15. Schwartz T.L., Masand P.S. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics. 43:2002;171-174.
16. Takatsuki M., Uemoto S., Inomata Y., et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation. 72:2001;449-454.
17. Personal communication, Arthur Matas, University of Minnesota, 1994.